VivoSim Labs (VIVS) Other Accumulated Expenses (2011 - 2026)
VivoSim Labs (VIVS) posted Other Accumulated Expenses of $9000.0 for Q2 2026, down 75.0% on a QoQ basis from $36000.0 in Q1 2026, and down 10.0% year-over-year from $10000.0 in Q2 2025.
Analysis
VivoSim Labs (VIVS) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Other Accumulated Expenses for 16 years, with the latest figure at $9000.0 in Q2 2026.
- On a quarterly basis, Other Accumulated Expenses fell 10.0% year-over-year to $9000.0 in Q2 2026; TTM through Jun 2026 was $9000.0, a 10.0% decrease from a year earlier, with the FY2026 full-year figure at $36000.0, down 38.98% from the prior year.
- Other Accumulated Expenses was $9000.0 for Q2 2026 at VivoSim Labs, down from $36000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $334000.0 in Q3 2023, with the low at $9000.0 in Q3 2025.
- Average Other Accumulated Expenses over 5 years is $84142.9, with a median of $52500.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses jumped 113.04% in 2024, then plunged 91.96% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $28000.0 in 2022, then surged by 582.14% to $191000.0 in 2023, then increased by 4.19% to $199000.0 in 2024, then slumped by 91.96% to $16000.0 in 2025, then sank by 43.75% to $9000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $9000.0 (Q2 2026), $36000.0 (Q1 2026), and $16000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 199,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 191,000.00 |
| Sep 30, 2023 | 334,000.00 |
| Mar 31, 2023 | 46,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Mar 31, 2021 | 31,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Mar 31, 2019 | 237,000.00 |
| Mar 31, 2018 | 507,000.00 |
| Mar 31, 2017 | 211,000.00 |
| Mar 31, 2016 | 61,000.00 |